BRCA1 and cancer: Among patients with HR+/HER2− ABC, overall BRCA1/2mut testing rates were lower for those who had no known family history of BRCA1/2-related cancer compared with those who did have a family history (67% vs. 84%, p = 0.030; Table 4).